Annual report
6942.TEDINET S100VYL7
Period2024-04-01 → 2025-03-31
Filed2025-06-24
StandardIFRS
ConsolidatedYes
Data checks16 of 26 passed
Key figures · 171
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥8.4bn | 2024-04-01 → 2025-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥9.0bn | 2023-04-01 → 2024-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥9.4bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.8bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.4bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥345m | 2024-04-01 → 2025-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥403m | 2023-04-01 → 2024-03-31 | Cons. | Operating profit loss IFRS |
| Ordinary income | −¥48m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥173m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥399m | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥889m | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥749m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥322m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥377m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥95m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥418m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥230m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥101m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥21m | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥613m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥502m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥95m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥230m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥7.5bn | at 2025-03-31 | Cons. | Assets IFRS |
| Total assets | ¥6.5bn | at 2025-03-31 | Cons. | Total assets (5-year summary) |
| Total assets | ¥8.3bn | at 2024-03-31 | Cons. | Assets IFRS |
| Total assets | ¥7.8bn | at 2024-03-31 | Cons. | Total assets (5-year summary) |
| Total assets | ¥7.7bn | at 2023-03-31d | Cons. | Assets IFRS |
| Total assets | ¥7.4bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥8.6bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥8.6bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.4bn | at 2025-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥5.5bn | at 2024-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥6.3bn | at 2023-03-31d | Cons. | Liabilities IFRS |
| Net assets / equity | ¥3.0bn | at 2025-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.8bn | at 2025-03-31 | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥2.8bn | at 2024-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥3.1bn | at 2024-03-31 | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥1.4bn | at 2023-03-31d | Cons. | Equity IFRS |
| Net assets / equity | ¥2.0bn | at 2023-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥2.0bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥1.4bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Equity (owners) | ¥3.0bn | at 2025-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥2.8bn | at 2024-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.4bn | at 2023-03-31d | Cons. | Equity attributable to owners of parent IFRS |
| Cash & equivalents | ¥2.7bn | at 2025-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥2.8bn | at 2024-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥3.0bn | at 2024-03-31 | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.0bn | at 2023-03-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥2.3bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.1bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥261m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥117m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥775m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥634m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥411m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.1bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥378m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | ¥377m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥27m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥39m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥151m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥86m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥848m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥704m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥191m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥332m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥694m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥696m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥793m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥20.79 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-91.21 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥76.4 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-33.5 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.85 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥228.11 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥186.65 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥20.71 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥73.68 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings loss per share IFRS |
| Net assets per share | ¥609.76 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥654.31 | at 2025-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥700.95 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥633.07 | at 2024-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥753.48 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥536.2 | at 2023-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥745.63 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥515.39 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 43.2% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.6% | at 2025-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 39.6% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.7% | at 2024-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 27.4% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 18.7% | at 2023-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 23.3% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 16.1% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | -14.1% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.3% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | -3.9% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.8% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 1.0% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 36.2% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 44.2% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 201 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 193 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 215 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 209 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 228 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥523m | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥278m | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥427m | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥395m | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥310m | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥57m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | −¥98m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | −¥534m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥124m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥106m | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥115m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥76m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥103m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥124m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | −¥83m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | −¥74m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥56m | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥149m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥216m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥3.0bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥3.1bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥2.5bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.0bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.6bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.0bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.2bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.0bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥828m | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥772m | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥623m | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.2bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-18.01 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-24.47 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.77 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.25 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥80.15 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥429.26 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥436.94 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥307.86 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥287.1 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥231.85 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 66.4% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.5% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.5% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.1% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | -4.2% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -5.3% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.0% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 21.3% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 41.8% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 4,677,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,483,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,737,000 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,737,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,737,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 9 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 8 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 10 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 9 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 10 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 56
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-03-31 | 0 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2025-03-31 | ¥10m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥10m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2025-03-31 | −¥45m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥26m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥26m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | ¥158m |
| Dispensing Pharmacy And Related Businessreportable segment | employees | at 2025-03-31 | 142 pure |
| Dispensing Pharmacy And Related Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥6.9bn |
| Dispensing Pharmacy And Related Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥6.9bn |
| Dispensing Pharmacy And Related Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥9m |
| Dispensing Pharmacy And Related Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥207m |
| Internet Related Businessreportable segment | employees | at 2025-03-31 | 47 pure |
| Internet Related Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.3bn |
| Internet Related Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.3bn |
| Internet Related Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥7m |
| Internet Related Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥50m |
| Telecommunications Businessreportable segment | employees | at 2025-03-31 | 3 pure |
| Telecommunications Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥153m |
| Telecommunications Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥143m |
| Telecommunications Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥10m |
| Telecommunications Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥25m |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥8.4bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥8.4bn |
| —segment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥26m |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥232m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥8.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥8.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥26m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥187m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2024-03-31 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2024-03-31 | −¥25m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2024-03-31 | −¥19m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2024-03-31 | −¥19m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥189m |
| Dispensing Pharmacy And Related Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥7.2bn |
| Dispensing Pharmacy And Related Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥7.2bn |
| Dispensing Pharmacy And Related Businessreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥9m |
| Dispensing Pharmacy And Related Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥527m |
| Internet Related Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥1.7bn |
| Internet Related Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥1.7bn |
| Internet Related Businessreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥4m |
| Internet Related Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥158m |
| Telecommunications Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥166m |
| Telecommunications Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥161m |
| Telecommunications Businessreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥6m |
| Telecommunications Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | −¥68m |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥9.0bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥9.0bn |
| —segment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥19m |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥617m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥9.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥9.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥19m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥592m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,623
| Item | Context | Value | Unit |
|---|---|---|---|
| Payments for acquisition of businesses inv cf IFRS | CurrentYearDuration | -64400000 | JPY |
| Proceeds from sale of businesses inv cf IFRS | Prior1YearDuration | 1538000 | JPY |
| Proceeds from sale of businesses inv cf IFRS | CurrentYearDuration | － | JPY |
| Payments for leasehold deposits and guarantee deposits inv cf IFRS | Prior1YearDuration | -3516000 | JPY |
| Payments for leasehold deposits and guarantee deposits inv cf IFRS | CurrentYearDuration | -9276000 | JPY |
| Proceeds from collection of leasehold deposits and guarantee deposits inv cf IFRS | Prior1YearDuration | 3980000 | JPY |
| Proceeds from collection of leasehold deposits and guarantee deposits inv cf IFRS | CurrentYearDuration | 25267000 | JPY |
| Payments for asset retirement obligations inv cf IFRS | Prior1YearDuration | － | JPY |
| Payments for asset retirement obligations inv cf IFRS | CurrentYearDuration | -31535000 | JPY |
| Net cash provided by used in investing activities IFRS | Prior1YearDuration | -27149000 | JPY |
| Net cash provided by used in investing activities IFRS | CurrentYearDuration | 377548000 | JPY |
| Proceeds from long term borrowings fin cf IFRS | Prior1YearDuration | － | JPY |
| Proceeds from long term borrowings fin cf IFRS | CurrentYearDuration | 222000000 | JPY |
| Repayments of long term borrowings fin cf IFRS | Prior1YearDuration | -730003000 | JPY |
| Repayments of long term borrowings fin cf IFRS | CurrentYearDuration | -1014831000 | JPY |
| Redemption of bonds fin cf IFRS | Prior1YearDuration | -57200000 | JPY |
| Redemption of bonds fin cf IFRS | CurrentYearDuration | -35000000 | JPY |
| Repayments of lease obligations fin cf IFRS | Prior1YearDuration | -141887000 | JPY |
| Repayments of lease obligations fin cf IFRS | CurrentYearDuration | -144058000 | JPY |
| Proceeds from issuance of shares fin cf IFRS | Prior1YearDuration | 242217000 | JPY |
| Proceeds from issuance of shares fin cf IFRS | CurrentYearDuration | － | JPY |
| Proceeds from exercise of share acquisition rights fin cf IFRS | Prior1YearDuration | 865670000 | JPY |
| Proceeds from exercise of share acquisition rights fin cf IFRS | CurrentYearDuration | 123849000 | JPY |
| Proceeds from issuance of share acquisition rights fin cf IFRS | Prior1YearDuration | 11842000 | JPY |
| Proceeds from issuance of share acquisition rights fin cf IFRS | CurrentYearDuration | － | JPY |
| Payments for purchase of treasury shares fin cf IFRS | Prior1YearDuration | -41000 | JPY |
| Payments for purchase of treasury shares fin cf IFRS | CurrentYearDuration | -20000 | JPY |
| Net cash provided by used in financing activities IFRS | Prior1YearDuration | 190596000 | JPY |
| Net cash provided by used in financing activities IFRS | CurrentYearDuration | -848060000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | Prior1YearDuration | -107000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | CurrentYearDuration | -91000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | Prior1YearDuration | 938675000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | CurrentYearDuration | -209184000 | JPY |
| Cash and cash equivalents if different from bs balance IFRS | Prior2YearInstant | 2017889000 | JPY |
| Cash and cash equivalents if different from bs balance IFRS | Prior1YearInstant | 2956565000 | JPY |
| Cash and cash equivalents if different from bs balance IFRS | Prior1YearInstant | 2956565000 | JPY |
| Cash and cash equivalents if different from bs balance IFRS | CurrentYearInstant | 2747381000 | JPY |
| Revenue from external customers IFRS | Prior1YearDuration_jpcrp030000-asr_E01978-000InternetRelatedBusinessReportableSegmentMember | 1707459000 | JPY |
| Revenue from external customers IFRS | Prior1YearDuration_jpcrp030000-asr_E01978-000TelecommunicationsBusinessReportableSegmentMember | 160746000 | JPY |
| Revenue from external customers IFRS | Prior1YearDuration_jpcrp030000-asr_E01978-000DispensingPharmacyAndRelatedBusinessReportableSegmentMember | 7161738000 | JPY |
| Revenue from external customers IFRS | Prior1YearDuration_ReportableSegmentsMember | 9029944000 | JPY |
| Revenue from external customers IFRS | Prior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1790000 | JPY |
| Revenue from external customers IFRS | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 9031734000 | JPY |
| Revenue from external customers IFRS | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Revenue from external customers IFRS | Prior1YearDuration | 9031734000 | JPY |
| Intersegment revenue IFRS | Prior1YearDuration_jpcrp030000-asr_E01978-000InternetRelatedBusinessReportableSegmentMember | 4035000 | JPY |
| Intersegment revenue IFRS | Prior1YearDuration_jpcrp030000-asr_E01978-000TelecommunicationsBusinessReportableSegmentMember | 5711000 | JPY |
| Intersegment revenue IFRS | Prior1YearDuration_jpcrp030000-asr_E01978-000DispensingPharmacyAndRelatedBusinessReportableSegmentMember | 9490000 | JPY |
| Intersegment revenue IFRS | Prior1YearDuration_ReportableSegmentsMember | 19238000 | JPY |
| Intersegment revenue IFRS | Prior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 26 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | mismatch |
| statement vs summary · net assets | mismatch |
| statement vs summary · net assets | mismatch |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | mismatch |
| statement vs summary · net income attributable to parent | mismatch |
| statement vs summary · operating cash flow | mismatch |
| statement vs summary · operating cash flow | mismatch |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | mismatch |
| statement vs summary · total assets | mismatch |
| statement vs summary · total assets | mismatch |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |